Discontinuation of mycophenolate mofetil treatment six months after kidney transplantation.

被引：0
|
作者：
vanGelder, T [1 ]
Yzermans, JNM [1 ]
RischenVos, J [1 ]
Weimar, W [1 ]
机构：
[1] UNIV ROTTERDAM HOSP,DEPT INTERNAL MED & SURG 1,ROTTERDAM,NETHERLANDS
来源：
KIDNEY INTERNATIONAL | 1997年 / 52卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：562 / 562
页数：1
相关论文
共 50 条
  • [21] Treatment of chronic allograft nephropathy with mycophenolate mofetil after kidney transplantation:: A Spanish Multicenter study
    Molina, MG
    Serón, D
    Del Moral, RG
    Carrera, M
    Sola, E
    Ullate, PG
    Capdevila, L
    Gentil, MA
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 335 - +
  • [22] The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation
    Jirasiritham, S
    Sumethkul, V
    Mavichak, V
    Chalermsanyakorn, P
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 2040 - 2042
  • [23] The role of mycophenolate mofetil in kidney transplantation revisited
    Maripuri, Saugar
    Kasiske, Bertram L.
    TRANSPLANTATION REVIEWS, 2014, 28 (01) : 26 - 31
  • [24] Mycophenolate mofetil for maintenance therapy in kidney transplantation
    Gonwa, TA
    CLINICAL TRANSPLANTATION, 1996, 10 (01) : 128 - 130
  • [25] Use of basiliximab with mycophenolate mofetil in kidney transplantation
    Baron, PW
    Weissman, J
    Ojogho, ON
    Sahney, S
    Cutler, D
    James, S
    Oculam, C
    Abdelhalim, F
    Nehlsen-Cannarella, SL
    Teichman, S
    Concepcion, W
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (08) : 2881 - 2884
  • [26] Pharmacokinetics of mycophenolate mofetil after blood stem cell transplantation.: Impact of conditioning therapy
    Jenke, A
    Renner, U
    Freiberg-Richter, J
    Röllig, C
    Babatz, J
    Ehninger, G
    Bornhäuser, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S183 - S183
  • [27] Mycophenolate Mofetil-Related Diarrhea and Beta-Glucuronidase Activity Following Kidney Transplantation.
    Onyeaghala, G. C.
    Elmer, S.
    Schladt, D.
    Yang, P.
    Wagner, M.
    Teigen, L.
    Al-Kofahi, M.
    Wu, B.
    Guan, W.
    Staley, C.
    Riad, S.
    Matas, A.
    Remmel, R.
    Oetting, W.
    Dorr, C. R.
    Jacobson, P.
    Israni, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1039 - 1039
  • [28] Role of mycophenolate mofetil in recurrent hepatitis C virus infection after liver transplantation.
    Ben-Ari, Z
    Papo, O
    Sulkes, J
    Mor, E
    Tur-Kaspa, R
    HEPATOLOGY, 2001, 34 (04) : 410A - 410A
  • [29] Mycophenolate mofetil and CSA as GVHD prophylaxis after allogeneic blood stem cell transplantation.
    Bornhauser, M
    Thiede, HM
    Schuler, SU
    Thiede, C
    Ehninger, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S117 - S117
  • [30] The influence of mycophenolate mofetil on the incidence and severity of cytomegalovirus primo infections after renal transplantation.
    ter Meulen, CG
    Wetzels, JFM
    Hilbrands, LB
    TRANSPLANTATION, 1999, 67 (07) : S128 - S128
12345